Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
14.02
-0.30 (-2.09%)
Jul 30, 2025, 4:00 PM - Market closed

Company Description

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States.

The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name.

It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey.

It markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Medifast, Inc.
Medifast logo
CountryUnited States
Founded1980
IndustryPersonal Services
SectorConsumer Discretionary
Employees504
CEODaniel Chard

Contact Details

Address:
100 International Drive, 18th Floor
Baltimore, Maryland 21202
United States
Phone410 581 8042
Websitemedifastinc.com

Stock Details

Ticker SymbolMED
ExchangeNYSE
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0000910329
CUSIP Number58470H101
ISIN NumberUS58470H1014
Employer ID13-3714405
SIC Code2090

Key Executives

NamePosition
Daniel R. ChardExecutive Chairman and Chief Executive Officer
James P. Maloney CPAChief Financial Officer
Anthony E. TyreeChief Business Operations Officer
Jason L. Groves Esq.Executive Vice President, General Counsel and Corporate Secretary
Nicholas M. JohnsonChief Field Operations Officer
Jonathan Barrett MacKenzieVice President of Finance and Chief Accounting Officer
Steven ZenkerVice President of Investor Relations
Claudia C. GreningerChief Human Resources Officer

Latest SEC Filings

DateTypeTitle
Jun 20, 20258-KCurrent Report
May 14, 2025SCHEDULE 13G/AFiling
May 5, 2025ARSFiling
Apr 29, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 29, 2025DEF 14AOther definitive proxy statements
Apr 28, 202510-QQuarterly Report
Apr 28, 20258-KCurrent Report
Feb 18, 202510-KAnnual Report
Feb 18, 20258-KCurrent Report
Jan 13, 2025UPLOADFiling